cd38 inhibitor and 5-amino-1mq synergy nad+ Inhibition of enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism The Pharmacology of CD38/NADase: An
The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link Rapid Discovery of CD38 Inhibitor via DNA Encoded Natural Product Library Screening CD38 is a key mediator of NAD+ depletion in the brain of ZIKV infected mice: iScience Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




